Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 14INDUSTRY 2UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Lung 1Locally Advanced Pancreatic Cancer 1Head and Neck Squamous Cell Cancer 1Esophageal Squamous Cell Carcinoma 1Breast Neoplasms 1Advanced Pancreatic Cancer 1

Interventions

Cisplatin 2nedaplatin 1durvalumab 1camrelizumab 1apatinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Paclitaxel 1Irinotecan 1Drug Therapy 1Capecitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Esophageal Squamous Cell Carcinoma × 130-nm albumin-bound paclitaxel × Clear all
NCT04390958 2022-03-15

Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

ChineseAMS

Phase 2 Unknown
70 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡